Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-09

Clinical Trial Update: Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia [NA]

View source ↗

Summary

A clinical trial investigating the efficacy of CBT-I combined with lemborexant for different subtypes of chronic insomnia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lemborexant (lemborexant)

Snippet

Sponsor: Laval University | Conditions: Insomnia Disorder | NA | Status: RECRUITING